BEAMSTART Logo

Take down tweets defaming allopath doctors: Delhi HC to Patanjali Ayurved

Business Standard LogoBusiness Standard6h ago

Take down tweets defaming allopath doctors: Delhi HC to Patanjali Ayurved - Business Standard

Quick Summary:

Such statements and representations are clearly contrary to, and in flagrant violation of, the statutory approvals, certifications, and licenses issued by the Ministry of AYUSH and/or by the licensing authorities, as detailed above," the court said.

Such misrepresentation will be a deterrent to the public, it said."A plain reading of the impugned material shows that the contesting defendants (Ramdev, Balkrishna, and Patanjali) have represented to the public-at-large that the said tablet (Coronil) is a treatment, medicine, and even cure for COVID-19.

The defamation suit claimed Ramdev and his associates had said that allopathy is responsible for the deaths of lakhs of people due to Covid and that allopathic doctors have been profiteering off the patients.


More Pictures

Take down tweets defaming allopath doctors: Delhi HC to Patanjali Ayurved - Business Standard (Picture 1)

or

Article Details

Category: BusinessFinance

Markets:

Topics:

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-07-29 @ 19:24:23 (6 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 679 words

Reading Time: 4 minutes read

Sentences: 23 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 21825157

View Article Analysis

About Business Standard

Business Standard Logo

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 309 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 3 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions

How long will it take to read this news story?

The story "Take down tweets defaming allopath doctors: Delhi HC to Patanjali Ayurved" has 679 words across 23 sentences, which will take approximately 3 - 6 minutes for the average person to read.

Which news outlet covered this story?

The story "Take down tweets defaming allopath doctors: Delhi HC to Patanjali Ayurved" was covered 6 hours ago by Business Standard, a news publisher based in India.

How trustworthy is 'Business Standard' news outlet?

Business Standard is a fully independent (privately-owned) news outlet established in 1975 that covers mostly business and finance news.

The outlet is headquartered in India and publishes an average of 309 news stories per day.

It's most recent story was published 3 hours ago.

What do people currently think of this news story?

The sentiment for this story is currently Negative, indicating that people regard this as "bad news".

How do I report this news for inaccuracy?

You can report an inaccurate news publication to us via our contact page. Please also include the news #ID number and the URL to this story.
  • News ID: #21825157
  • URL: https://beamstart.com/news/take-down-tweets-defaming-allopath-17222622945538

BEAMSTART

BEAMSTART is a global entrepreneurship community, serving as a catalyst for innovation and collaboration. With a mission to empower entrepreneurs, we offer exclusive deals with savings totaling over $1,000,000, curated news, events, and a vast investor database. Through our portal, we aim to foster a supportive ecosystem where like-minded individuals can connect and create opportunities for growth and success.

© Copyright 2024 BEAMSTART. All Rights Reserved.